Intraoperative near-infrared fluorescence imaging of colorectal carcinoma with cRGD-ZW800-1 and dedicated imaging systems: A Phase II study

eiden University Medical Center0 个研究点目标入组 12 人开始时间: 2017年8月9日最近更新: 2018年3月5日

试验速览

暂无简介。

•1) Patients > 18 years old;
•2) Patients scheduled and eligible for resection because of colorectal carcinoma;
•3) Patients should be capable and willing to give informed consent before study specific procedures;
•4) Screening ECG and clinical laboratory test results are within normal limits, or if any are outside of normal limits they are considered to be clinically insignificant;
•5) The patient has a normal or clinically acceptable medical history, physical examination, and vital signs findings at screening;
•6) Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 12
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 12

•1) History of a clinically significant allergy or anaphylactic reactions;
•2) Patients pregnant or breastfeeding, lack of effective contraception in male or female patients with reproductive potential;
•3) Any condition that the investigator considers to be potentially jeopardizing the patients well-being or the study objectives.

发起方

eiden University Medical Center